The Galien Foundation Announces 2024 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
NEW YORK, Aug. 13, 2024 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the 2024 Prix Galien USA Award nominees for "Best Digital Health Solution," "Best Medical Technology," and "Incubators, Accelerators and Equity." Nominees have also been announced for "Best Startup," in partnership with Business France. Winners will be announced during the Prix Galien USA Forum on November 7, 2024, at the Alexandria Center for Life Science in New York City. Nominees for "Best Medical Technology" will be previewed during the Prix Galien USA Forum, before the remaining category winners are announced during the Prix Galien USA Awards Ceremony at the American Museum of Natural History in New York City.
This year marks the tenth anniversary of The Galien Foundation and Business France recognizing global innovators in the "Best Startup" category. This partnership supports global healthcare startups by offering visibility on the American stage and connecting them with major players in the industry in the U.S. and Canada.
"Healthcare innovation is a global endeavor, and we are thrilled to celebrate ten years of partnering with The Galien Foundation. Together, we award excellence in life sciences and biopharmaceuticals while fostering relationships between startups, potential collaborators and investors," said Frederic Rossi, CEO Business France North America.
New this year, Northwell Health, in collaboration with The Galien Foundation, will serve as a U.S. landing pad for all companies honored with the prestigious Prix Galien Awards in the categories of Best Digital Health Solution, Best Medical Technology, Best Startup and Best Incubator, Accelerator, Equity. This collaboration provides a platform for healthcare innovators recognized by The Galien Foundation to access the U.S. healthcare market with the support and guidance of Northwell Health.
"By bringing together brilliant minds and dedicated professionals, we invigorate more research and development, and opportunity for collaboration in the life sciences. This synergy not only accelerates innovation but also brings us closer to even more groundbreaking solutions that can transform patient care, said Bruno Cohen, Chairman of The Galien Foundation. "We look forward to celebrating the power of partnerships and recognizing excellence in innovation with all nominees in November."
Best Digital Health Solution (Nominees)
Abbott
NeuroSphere(TM) Virtual Clinic
Aptar Digital Health Migraine Buddy's Weather and Trigger Advanced
Reports
BigHat Biosciences
BigHat
Clinical ink
GlucoseReady(TM)
Cognoa
Canvas Dx ASD Diagnostic Aid
Empatica
Empatica Health Monitoring Platform
Excientia Exscientia's end-to-end AI-driven precision
medicine platform
MPA
MyPsychAdmin
Mymee
Mymee
Omnyk
OmnyKare
Patientory, Inc
Patientory Digital Health Data Wallet
RapidAI
Clinical AI and Workflow Solutions
Revibe Technologies
FokusRx
Roche Diagnostics
Accu-Chek SmartGuide Predict app
Science37
Science37
TECHMEDO
Healthcare Operating System
University of Rochester - Wilmot Cancer Institute University of Rochester -Wilmot Cancer
Institute's Hyperion
Viz.ai
Viz HCM(TM)
Withings
Body Scan
Zuri Health
Zuri Health
Best Medical Technology (Nominees)
Abbott
AVEIR(TM) Dual Chamber (DR) Leadless Pacemaker System
Abbott
TRICLIP(TM) G4 SYSTEM. Treatment of tricuspid regurgitation
Alcon
Vivity(R) Extended Vision IOL
Alcon
TOTAL30(R) Soft Contact Lenses
Bausch + Lomb
XIPERE(R)
Body Vision Medical LTD.
LungVision(R)
Boston Scientific
ELUVIA(TM) Drug-Eluting Vascular Stent System
Boston Scientific
SpaceOAR VUE(TM) Hydrogel
Butterfly Network
Butterfly iQ3(TM) Handheld Ultrasound System
Edwards Lifesciences Edwards EVOQUE Transcatheter Tricuspid Valve Replacement System
Edwards Lifesciences Edwards SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra
Adaptive Prestent
Edwards Lifesciences Edwards SAPIEN 3 Ultra RESILIA Transcatheter Aortic Heart Valve
ENDOLOGIX LLC
DETOUR System
Guardant Health
Guardant360(R) CDx
HistoSonics Inc
Edison Histotripsy System
Impel Pharmaceuticals Inc.
Trudhesa(R)
Impulse Dynamics
Optimizer(R) Smart Mini System
LifeVac, LLC
LifeVac
Medtronic
Inceptiv(TM) SCS
Medtronic
MiniMed(TM) 780G automated insulin delivery system
Medtronic
Symplicity Spyral(TM) Renal Denervation System
Olympus America Inc.
BF-UC190F Endobronchial Ultrasound (EBUS) Bronchoscope
Organon
The Jada(R) System
Outset Medical, Inc.
Tablo(R) Hemodialysis System
Polarean
XENOVIEW HPX System
RefleXion Medical
RefleXion(R) X1 with SCINTIX(R) biology-guided radiotherapy
Smith & Nephew, Inc.
CORI Surgical System
Standard Bariatrics, Inc.
Titan SGS(R)
Terumo Aortic
Thoraflex Hybrid(TM)
Incubators, Accelerators and Equity (Nominees)
Cedars-Sinai
Cedars-Sinai Accelerator
Cross-Border Impact Ventures Women's and Children's Health Technology Fund
Cube Labs
CUBE LABS
EIT Health
EIT Health Accelerator
MATTER
MATTER Startup Incubation
Mayo Foundation for Medical Education and Research Mayo Clinic and Arizona State University MedTech
Accelerator
McGill Dobson Centre for Entrepreneurship McGill Dobson Centre for Entrepreneurship
OROT - CIUSS Montreal
OROT - CIUSS Montreal
TechConnect
TechConnect Venture Studio
TMC Innovation
Texas Medical Center Innovation
Best Startup (Nominees)
Acorai AB
Actipulse Neuroscience
Advanced Biodesign
Alga Biologics
Axoltis Pharma
Basys.AI
BHealthCare
Bloqcube Inc.
Canary Medical / SBC Global
Carcinotech
Cellarity
CervoMed Inc.
Click Therapeutics
Coastar Therapeutics Inc.
DeepLife
Delix Therapeutics
Domain Therapeutics
Duo Oncology
Gameto
Ganymed Robotics
Halia Therapeutics, Inc.
Immunis, Inc.
Innerstill
J&T Medical
Lazurite
Lifebloom
Lisata Therapeutics, Inc.
Logix Biosciences Inc
Manus Neurodynamica
Micron Biomedical, Inc.
MindMics Inc.
Navigation Sciences, Inc.
OUI Inc.
Pentavere
Poladerme
Qubit Pharmaceuticals
SIMEDYS
Skinosive
Smartcatch
TargED Biopharmaceuticals B.V.
Tribun Health
ViCardia Therapeutics, Inc.
Ymmunobio
The 2024 Prix Galien USA Medical Technology, Digital Health, Incubators, Accelerators and Equity, and Startup Awards Committee is composed of nine renowned leaders from the biomedical industry and academia, responsible for evaluating nominees. The 2024 Prix Galien Sub-Committees and Advisory Boards conduct a pre-screening of all applications before submitting the shortlist of award candidates to the Awards Committee.
Prix Galien Medical Technology, Digital Health, Incubators, Accelerators and Equity, and Startup Awards Committee 2024
Kenneth C. FRAZIER
Committee Chair, Former Chairman & CEO Merck
Roch DOLIVEUX
Honorary CEO, UCB
Dr. Mikael DOLSTEN
Chief Scientific Officer & President, Pfizer Research and Development
Alex GORSKY
Former CEO & Executive Chairman, Johnson & Johnson
Penny HEATON
Global Therapeutic Area Head, Vaccines, Janssen
Sheri McCOY
Board of Directors, AstraZeneca, Former CEO, Avon
François MAISONROUGE
Senior Managing Director, Evercore Partners
Joel S. MARCUS
Executive Chairman & Founder, Alexandria
Elias ZERHOUNI
Former Head of Global R&D, Sanofi
Prix Galien Medical Technology Sub-Committee 2024
Lisa EARNHARDT
Executive Vice President, Medical Devices, Abbott
Robert S. LANGER
David H. Koch Institute Professor, Massachusetts Institute of Technology
Cato T. LAURENCIN
M.D., Ph.D., University Professor, University of Connecticut
Steven LESTER
M.D., Chief Medical Officer, Mayo Clinic-ASU MedTech Accelerator
Michel PAIRET
Head of Innovation Unit- Board of Managing Directors, Boehringer Ingelheim
Prix Galien Incubators, Accelerators, and Equity Category Sub Committee 2024
Gil BASHE
Managing Partner, Chair Global Health and Purpose, FINN Partners
Ron COHEN
M.D., Founder, President & CEO, Acorda Therapeutics
Jamey EDWARDS
Former CEO, Emergent Medical Associates
Amir KALALI
M.D., Chairman & Chief Curator CNS Summit/Co-Chair Decentralized Trial Research Alliance
Michelle LONGMIRE
M.D., Co-Founder & CEO, Medable Inc.
Cheryl PEGUS
M.D., Executive Vice President of Health & Wellness, Walmart
James PRUTOW
J.D., MBA, Advisory Partner - Life Sciences, Molecular Diagnostics, Global Healthcare, PwC Consulting
Prix Galien Startup Advisory Board 2024
Gaye BOK
Ph.D., Partner, AI and Digital Innovation Fund, Mass General Brigham
Christine BRENNAN
Ph.D., Managing Director, Vertex Venture HC
Elaine Brennan
Executive Director, Global Strategic Partnerships, Northwell Health
Luba GREENWOOD
Managing Partner, Dana Farber Cancer Institute Venture Fund
Rodolphe KATRA
Ph.D.,Sr. Research Director & Technical Fellow, Medtronic
Michael LANGER
Founder and Managing Partner at T.Rx Capital
Jonathan MARCHADO
Managing Director, Samsung Next
Detlev MENNERICH
Corporate SVP, Global Head of Business Development & Licensing (BD&L), Boehringer Ingelheim
Amir NAIBERG
Ass. Vice Chancellor, Technology Development Group, UCLA
Leighanne OH
MS, Life Sciences Investor, Novo Holding
Denis PATRIC
Ph.D., Emerging Science & Innovation, Partnering, Pfizer
Dennis PURCELL
Founder, Aisling Capital
Uciane SCARLETT
Ph.D., Partner, MPM Capital
Prix Galien Digital Health Advisory Board 2024
Junaid BAJWA
Chief Medical Scientist, Microsoft Research, Microsoft
Sachin NANAVATI
Head, Industry, Healthcare, Google
Jay RAJDA
M.D., Clinical Leader, Healthcare, Amazon
MaryAnne RIZK
Ph.D., Managing Partner, Rizk Management Advisors, Adjunct Professor, Stevens Institute of Technology
Steven ROSENBERG
Chief Executive Officer, uMotif
Daniel VIAL
Former Advisor of Sanofi CEO, Healthcare Consultant
About The Galien Foundation
The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives. The late Professor Elie Wiesel, 1986 Peace Nobel Laureate, is The Honorary Founding President of The Galien Foundation
The Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries, Africa and an inaugural chapter established in India in 2024. The Prix Galien was created in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.
For more information, visit?www.galienfoundation.org.
Follow the Foundation on social media:
https://www.facebook.com/GalienFoundation/
https://twitter.com/GalienFdn
https://www.linkedin.com/company/the-galien-foundation/
Media Contact:
Kara Bradley
Finn Partners
Kara.Bradley@finnpartners.com
646-213-7243
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-galien-foundation-announces-2024-prix-galien-usa-nominees-for-best-digital-health-solution-best-medical-technology-incubators-accelerators-and-equity-and-best-startup-302220657.html
SOURCE The Galien Foundation
